Kamala Harris (BK22990) Stock Forum and Discussion

Kamala Harris Watchlist

The list includes stocks closely associated with business dealings, political actions, or events related to Kamala Harris. These stocks may benefit from Harris's potential win in the 2024 US presidential election.

1923.279
+7.192+0.38%

Trading Oct 15 10:21 ET

1930.719High1914.618Low

Constituent Stocks: 21Top Rising: TEVA+3.54%

10baggerbamm

1 minute ago

$MicroStrategy (MSTR.US)$ I told everybody to buy puts you can go back and read I got mocked and ridiculed and laughed at I told you all to buy the puts under the 2x leverage ETF.. trees don't grow to the sky
told everybody to buy the bear 2X ETF and to buy calls on the bear 2x e ETF you can go back and read about that too and look how that is climbing oh my God man it's raining money baby

In One Chart

5 minutes ago

Columns Bitcoin Surges Nearly 55% This Year, Outpacing Global Assets – What's Next for Its Market Performance?

U.S. presidential candidate and current Vice President Harris pledged support for a regulatory framework for digital currencies. The news spurred a surge in the cryptocurrency market, with Bitcoin rising by 6% during the day to $66,233, its highest level in two weeks. Ethereum also climbed above $2,600.
As of the time of writing, Bitcoin has slightly pulled back, but remains above $65,000. Notab...

Crypto rally: Is this a big comeback for Bitcoin?

JensenBaby

7 minutes ago

$Amazon (AMZN.US)$ why so fking weak

mad541

10 minutes ago

$Amazon (AMZN.US)$ breaking news big $Meiragtx Holdings Plc just cured Parkinson disease treatment 🔥🔥🔥👀 news today

104068117

16 minutes ago

Bitcoin bullish

$MicroStrategy (MSTR.US)$

Growth Investor27

19 minutes ago

Buyout offer Could be $10+ For Esperion And Could Happen Before 2025

$Esperion Therapeutics (ESPR.US)$ The recent analyst note from Jeff sugest Esperion might sell the entire rights for Bempedoic Acid. Fair valuation on the rights would be above $1.5 billion, based on future milestones $900 million, future royalties & patents, the current formulation patent has exp date Dec 2031. The potential yearly sales in the U.S could reach $4 billion by 2027.
Esperion could also partner in the U.S .
Keep an...